Revolution Medicines, Inc. (RVMD)

152.48 +5.47 (+3.72%) USD  |  NASDAQ  |  Apr 15, 16:00
152.31 -0.17 (-0.11%) After-Hours: 18:21
More

Revolution Medicines Research and Development Expense (Annual) : 978.68M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Merck & Co., Inc. 12.51B
Tango Therapeutics, Inc. 129.88M
AbbVie, Inc. 8.249B
AtriCure, Inc. 90.17M
Insmed, Inc. 771.09M